MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk

about

MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects.Polymorphisms of the Ras-Association Domain Family 1 Isoform A (RASSF1A) Gene are Associated with Ovarian Cancer, and with the Prognostic Factors of Grade and Stage, in Women in Southern China.

P2860

Q40088470-A56086E4-98AB-4FE3-AA81-D483E7F5CCE1 Q55114053-FBD4EE73-AA10-480E-9E69-281D0820DE6B

P2860

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk

Item

http://www.wikidata.org/entity/Q36270358

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

MDM2 promoter polymorphism del ...... etrial and ovarian cancer risk

@ast

MDM2 promoter polymorphism del ...... etrial and ovarian cancer risk

@en

type

Item

label

MDM2 promoter polymorphism del ...... etrial and ovarian cancer risk

@ast

MDM2 promoter polymorphism del ...... etrial and ovarian cancer risk

@en

prefLabel

MDM2 promoter polymorphism del ...... etrial and ovarian cancer risk

@ast

MDM2 promoter polymorphism del ...... etrial and ovarian cancer risk

@en

P1476

MDM2 promoter polymorphism del ...... etrial and ovarian cancer risk

@en

P2093

Anne Dørum

http://www.w3.org/2001/XMLSchema#string

Helga B Salvesen

http://www.w3.org/2001/XMLSchema#string

Liv B Gansmo

http://www.w3.org/2001/XMLSchema#string

Mari Kyllesø Halle

http://www.w3.org/2001/XMLSchema#string

Merete Bjørnslett

http://www.w3.org/2001/XMLSchema#string

P2860

Mdm2 promotes the rapid degradation of p53

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

Regulation of p53 stability by Mdm2

Amplification of a gene encoding a p53-associated protein in human sarcomas

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.

Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis

MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.

MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis.

P2888

s12885-017-3094-y

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3094-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083534649

http://www.w3.org/2001/XMLSchema#string

P698

28158999

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5291962

http://www.w3.org/2001/XMLSchema#string

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk

about

P2860

P2860

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932